Lung Cancer

1

A nomogram to predict brain metastasis as the first relapse in curatively resected non-small cell lung cancer patients

Won, Young-Woong, Joo, Jungnam, Yun, Tak, Lee, Geon-Kook, Han, Ji-Youn, Kim, Heung Tae, Lee, Jin Soo, Kim, Moon Soo, Lee, Jong Mog, Lee, Hyun-Sung, Zo, Jae Ill, Kim, Sohee

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 282 KB

english, 2015

2

Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC

Sorensen, Steffen Filskov, Carus, Andreas, Meldgaard, Peter

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 378 KB

english, 2015

3

Identification of biomarkers for the detection of early stage lung adenocarcinoma by microarray profiling of long noncoding RNAs

Wang, Ping, Lu, Shaohua, Mao, Hailei, Bai, Yanan, Ma, Tianle, Cheng, Zule, Zhang, Honglian, Jin, Qinghui, Zhao, Jianlong, Mao, Hongju

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.96 MB

english, 2015

4

High-dose conventional thoracic re-irradiation for lung cancer: Updated results

Tetar, Shyama, Dahele, Max, Griffioen, Gwendolyn, Slotman, Ben, Senan, Suresh

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 166 KB

english, 2015

5

Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma

Katsuya, Yuki, Fujita, Yu, Horinouchi, Hidehito, Ohe, Yuichiro, Watanabe, Shun-ichi, Tsuta, Koji

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.48 MB

english, 2015

6

Fruit and vegetable consumption and risk of lung cancer: A dose–response meta-analysis of prospective cohort studies

Wang, Yaopeng, Li, Fei, Wang, Zizong, Qiu, Tong, Shen, Yi, Wang, Mingzhao

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.38 MB

english, 2015

7

I1171 missense mutation (particularly I1171N) is a common resistance mutation in ALK-positive NSCLC patients who have progressive disease while on alectinib and is sensitive to ceritinib

Ou, Sai-Hong Ignatius, Greenbowe, Joel, Khan, Ziad U., Azada, Michele C., Ross, Jeffrey S., Stevens, Phil J., Ali, Siraj M., Miller, Vincent A., Gitlitz, Barbara

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.08 MB

english, 2015

8

Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression

Mao, Kaisheng, Liu, Fakeng, Liu, Xiuju, Khuri, Fadlo R., Marcus, Adam I., Li, Mingsong, Zhou, Wei

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 2.13 MB

english, 2015

9

Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion

Tsai, Tzu-Hsiu, Wu, Shang-Gin, Hsieh, Min-Shu, Yu, Chong-Jen, Yang, James Chih-Hsin, Shih, Jin-Yuan

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 867 KB

english, 2015

10

Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib

Wu, Kuan-Li, Tsai, Ming-Ju, Yang, Chih-Jen, Chang, Wei-An, Hung, Jen-Yu, Yen, Chun-Ju, Shen, Chi-Hsiang, Kuo, Tzu-Yu, Lee, Jui-Ying, Chou, Shah-Hwa, Liu, Ta-Chih, Chong, Inn-Wen, Huang, Ming-Shyan

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 768 KB

english, 2015

11

Multiple resistant factors in lung cancer with primary resistance to EGFR-TK inhibitors confer poor survival

Kim, Go Woon, Song, Joon Seon, Choi, Chang-Min, Rho, Jin Kyung, Kim, Sun Ye, Jang, Se Jin, Park, Young Soo, Chun, Sung-Min, Kim, Woo Sung, Lee, Jung-Shin, Kim, Sang-We, Lee, Dae Ho, Lee, Jae Cheol

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.91 MB

english, 2015

12

Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancer

Howell, Matthew, Lee, Rebecca, Bowyer, Samantha, Fusi, Alberto, Lorigan, Paul

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 373 KB

english, 2015

13

Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study

Moro-Sibilot, Denis, Smit, Egbert, de Castro Carpeño, Javier, Lesniewski-Kmak, Krzysztof, Aerts, Joachim, Villatoro, Rosa, Kraaij, Kees, Nacerddine, Karim, Dyachkova, Yulia, Smith, Karen T., Taipale,

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 2.53 MB

english, 2015

14

Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC)

Garrido, Pilar, Engel-Riedel, Walburga, Serke, Monika, Giraud, Philippe, Ricardi, Umberto, Vallejo, Carmen, Visseren-Grul, Carla, Ameryckx, Sophie, Soldatenkova, Victoria, Chouaki, Nadia, Novello, Sil

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 712 KB

english, 2015

15

Prognostic factors for cases with no extracranial metastasis in whom brain metastasis is detected after resection of non-small cell lung cancer

Bae, Mi Kyung, Yu, Woo Sik, Byun, Go Eun, Lee, Chang Young, Lee, Jin Gu, Kim, Dae Joon, Chung, Kyung Young

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 637 KB

english, 2015

16

Achieving a tissue diagnosis in PS3 patients with advanced lung cancer: What are the safety and diagnostic outcomes with EBUS?

Al-Najjar, Haider, Evison, Matthew, Crosbie, Philip A.J., Martin, Julie, Barber, Philip V., Booton, Richard

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 110 KB

english, 2015

17

Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: Extended analysis of the PROSE trial

Hornberger, John, Hirsch, Fred R., Li, Qianyi, Page, Ray D.

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 637 KB

english, 2015

18

Factors associated with a poor response to gefitinib in the NEJ002 study: Smoking and the L858R mutation

Fukuhara, Tatsuro, Maemondo, Makoto, Inoue, Akira, Kobayashi, Kunihiko, Sugawara, Shunichi, Oizumi, Satoshi, Isobe, Hiroshi, Gemma, Akihiko, Harada, Masao, Yoshizawa, Hirohisa, Kinoshita, Ichiro, Fuji

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.17 MB

english, 2015

19

Editorial Board

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 57 KB

english, 2015

20

Volume 88; Issue 2

A nomogram to predict brain metastasis as the first relapse in curatively resected non-small cell lung cancer patients

Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC

Identification of biomarkers for the detection of early stage lung adenocarcinoma by microarray profiling of long noncoding RNAs

High-dose conventional thoracic re-irradiation for lung cancer: Updated results

Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma

Fruit and vegetable consumption and risk of lung cancer: A dose–response meta-analysis of prospective cohort studies

I1171 missense mutation (particularly I1171N) is a common resistance mutation in ALK-positive NSCLC patients who have progressive disease while on alectinib and is sensitive to ceritinib

Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression

Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion

Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib

Multiple resistant factors in lung cancer with primary resistance to EGFR-TK inhibitors confer poor survival

Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancer

Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study

Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC)

Prognostic factors for cases with no extracranial metastasis in whom brain metastasis is detected after resection of non-small cell lung cancer

Achieving a tissue diagnosis in PS3 patients with advanced lung cancer: What are the safety and diagnostic outcomes with EBUS?

Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: Extended analysis of the PROSE trial

Factors associated with a poor response to gefitinib in the NEJ002 study: Smoking and the L858R mutation

Editorial Board

Contents